<p>Panel A—The diameters of CD4<sup>+</sup>, CD8<sup>+</sup> and B cell populations isolated from spleens of GIMAP6<sup>fl/fl</sup> and GIMAP6<sup>fl/fl</sup>CD2Cre animals were measured using an electronic counter (CASY® Cell Counter + Analyser System—Schärfe System GMBH). Panel B–total splenic or lymph node-derived cells were stained for CD4 and then with antibodies to CD62L and CD44. Naïve cells were identified as CD62L<sup>+</sup>CD44<sup>-</sup>and memory cells as CD62L<sup>-</sup>CD44<sup>+</sup>. Graphs show each population expressed as a percentage of CD4<sup>+</sup> cells. n = 6. P values as follows: **P<0.001 **** P<0.0001; n = 6 for each group (unpaired 2-tailed Student’s t test).</p
<p>(A) Flow cytometry profiles for CD4 and CD8 of splenocytes from WT and Rasal3-KO mice (left). The...
<p>(A) Plots depict CD44 and CD62L expression on splenic <i>Hdac1<sup>f/f</sup></i> and <i>Hdac1<sup...
<p>Splenocytes from C57BL/6 WT, C57BL/6 WT treated with CTLA4Ig or CD28<sup>−/−</sup> recipients of ...
<p>Total splenic or lymph node-derived cells were stained for CD8 and then with an antibody to CD44....
<p>A) CD4<sup>+</sup> enriched naïve splenocytes from GIMAP6<sup>fl/fl</sup> and GIMAP6<sup>fl/fl</s...
<p>There is an increase in CD4 positive cells that express memory markers CD62L<sup>lo</sup>CD44<sup...
<p>(A) Representative dot plot of effector and central memory of CD4<sup>+</sup> and CD8a<sup>+</sup...
<p>Splenocytes isolated from Balb/c and NOD mice were stained with PE-Cy5-conjugated anti-CD4, FITC-...
<p>Young (2–4 mo old) or middle-aged (7–14 mo old) mice were sacrificed and spleen cell suspensions ...
<p>A) Splenocytes isolated from GIMAP6<sup>fl/fl</sup> and GIMAP6<sup>fl/fl</sup>CD2Cre animals were...
<p>Draining lymph nodes were collected the mice of 5 days after the DNFB or vehicle application mice...
<p>One week after the last immunization, spleen cells from IT/Saline, IT/rSm22.6, IT/rSm29, rSm22.6 ...
<p>Cells from spleens and dLNs from 20 weeks wide-type and <i>lpg2–</i>infected mice were stained wi...
<p>Spleen cells isolated from six week BCG immunized mice were stained for cytokine production by IC...
<p>2 × 10<sup>6</sup> lymphocytes were stained with anti-CD8-APC, anti-CD44-FITC and anti-CD62L-PE. ...
<p>(A) Flow cytometry profiles for CD4 and CD8 of splenocytes from WT and Rasal3-KO mice (left). The...
<p>(A) Plots depict CD44 and CD62L expression on splenic <i>Hdac1<sup>f/f</sup></i> and <i>Hdac1<sup...
<p>Splenocytes from C57BL/6 WT, C57BL/6 WT treated with CTLA4Ig or CD28<sup>−/−</sup> recipients of ...
<p>Total splenic or lymph node-derived cells were stained for CD8 and then with an antibody to CD44....
<p>A) CD4<sup>+</sup> enriched naïve splenocytes from GIMAP6<sup>fl/fl</sup> and GIMAP6<sup>fl/fl</s...
<p>There is an increase in CD4 positive cells that express memory markers CD62L<sup>lo</sup>CD44<sup...
<p>(A) Representative dot plot of effector and central memory of CD4<sup>+</sup> and CD8a<sup>+</sup...
<p>Splenocytes isolated from Balb/c and NOD mice were stained with PE-Cy5-conjugated anti-CD4, FITC-...
<p>Young (2–4 mo old) or middle-aged (7–14 mo old) mice were sacrificed and spleen cell suspensions ...
<p>A) Splenocytes isolated from GIMAP6<sup>fl/fl</sup> and GIMAP6<sup>fl/fl</sup>CD2Cre animals were...
<p>Draining lymph nodes were collected the mice of 5 days after the DNFB or vehicle application mice...
<p>One week after the last immunization, spleen cells from IT/Saline, IT/rSm22.6, IT/rSm29, rSm22.6 ...
<p>Cells from spleens and dLNs from 20 weeks wide-type and <i>lpg2–</i>infected mice were stained wi...
<p>Spleen cells isolated from six week BCG immunized mice were stained for cytokine production by IC...
<p>2 × 10<sup>6</sup> lymphocytes were stained with anti-CD8-APC, anti-CD44-FITC and anti-CD62L-PE. ...
<p>(A) Flow cytometry profiles for CD4 and CD8 of splenocytes from WT and Rasal3-KO mice (left). The...
<p>(A) Plots depict CD44 and CD62L expression on splenic <i>Hdac1<sup>f/f</sup></i> and <i>Hdac1<sup...
<p>Splenocytes from C57BL/6 WT, C57BL/6 WT treated with CTLA4Ig or CD28<sup>−/−</sup> recipients of ...